-
Something wrong with this record ?
The Effects of Intrapartum Administration of Synthetic Oxytocin on Breastfeeding in the First 9 Months Postpartum: A Longitudinal Prospective Study
L. Takács, F. Bartoš, P. Čepický, Š. Kaňková
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
34463162
DOI
10.1089/bfm.2020.0260
Knihovny.cz E-resources
- MeSH
- Child MeSH
- Breast Feeding MeSH
- Humans MeSH
- Oxytocin * adverse effects MeSH
- Postpartum Period MeSH
- Labor, Obstetric * MeSH
- Prospective Studies MeSH
- Pregnancy MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Background and Objective: Synthetic oxytocin (synOT) is a widely used drug to induce or accelerate labor and to prevent postpartum hemorrhage. Although some studies indicate there are associations between intrapartum synOT and impaired breastfeeding initiation or earlier cessation, the long-term effects of synOT on breastfeeding are largely understudied. The aim of this study was to examine the effects of synOT on breastfeeding status during the first 9 months postpartum. Materials and Methods: The women were recruited from five maternity hospitals during prenatal medical checkups or postpartum hospital stay. They reported their breastfeeding status on discharge from maternity hospital (mean 4.54 days postpartum) (N = 439), at 6 weeks (N = 439), and at 9 months postpartum (N = 274). The data related to synOT administration were extracted from the medical records. Results: In the analysis adjusted for maternal age, parity, educational level, marital status, child's sex, delivery mode, and labor analgesia/anesthesia, intrapartum administration of synOT predicted a lower probability of exclusive breastfeeding on discharge from maternity hospital (odds ratio = 0.37; p = 0.006), but we observed no effect on breastfeeding status at 6 weeks or 9 months postpartum. Conclusion: Our results suggest that adverse effects of synOT on breastfeeding do not persist beyond the first postpartum days.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22019611
- 003
- CZ-PrNML
- 005
- 20220804135825.0
- 007
- ta
- 008
- 220720s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1089/bfm.2020.0260 $2 doi
- 035 __
- $a (PubMed)34463162
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Takács, Lea $u Department of Psychology, Faculty of Arts, Charles University, Prague, Czech Republic $1 https://orcid.org/000000028137026X $7 ola2012732917
- 245 14
- $a The Effects of Intrapartum Administration of Synthetic Oxytocin on Breastfeeding in the First 9 Months Postpartum: A Longitudinal Prospective Study / $c L. Takács, F. Bartoš, P. Čepický, Š. Kaňková
- 520 9_
- $a Background and Objective: Synthetic oxytocin (synOT) is a widely used drug to induce or accelerate labor and to prevent postpartum hemorrhage. Although some studies indicate there are associations between intrapartum synOT and impaired breastfeeding initiation or earlier cessation, the long-term effects of synOT on breastfeeding are largely understudied. The aim of this study was to examine the effects of synOT on breastfeeding status during the first 9 months postpartum. Materials and Methods: The women were recruited from five maternity hospitals during prenatal medical checkups or postpartum hospital stay. They reported their breastfeeding status on discharge from maternity hospital (mean 4.54 days postpartum) (N = 439), at 6 weeks (N = 439), and at 9 months postpartum (N = 274). The data related to synOT administration were extracted from the medical records. Results: In the analysis adjusted for maternal age, parity, educational level, marital status, child's sex, delivery mode, and labor analgesia/anesthesia, intrapartum administration of synOT predicted a lower probability of exclusive breastfeeding on discharge from maternity hospital (odds ratio = 0.37; p = 0.006), but we observed no effect on breastfeeding status at 6 weeks or 9 months postpartum. Conclusion: Our results suggest that adverse effects of synOT on breastfeeding do not persist beyond the first postpartum days.
- 650 _2
- $a kojení $7 D001942
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a porodní děj $7 D007743
- 650 12
- $a oxytocin $x škodlivé účinky $7 D010121
- 650 _2
- $a poporodní období $7 D049590
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a prospektivní studie $7 D011446
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bartoš, František $u Department of Psychology, Faculty of Arts, Charles University, Prague, Czech Republic
- 700 1_
- $a Čepický, Pavel $u Department of Psychology, Faculty of Arts, Charles University, Prague, Czech Republic
- 700 1_
- $a Kaňková, Šárka $u Department of Philosophy and History of Science, Faculty of Science, Charles University, Prague, Czech Republic $u Department of Applied Neurosciences and Brain Imagination, National Institute of Mental Health, Klecany, Czech Republic $1 https://orcid.org/0000000230877538 $7 xx0112131
- 773 0_
- $w MED00173017 $t Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine $x 1556-8342 $g Roč. 16, č. 12 (2021), s. 965-970
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34463162 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804135818 $b ABA008
- 999 __
- $a ok $b bmc $g 1822996 $s 1170854
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 16 $c 12 $d 965-970 $e 20210831 $i 1556-8342 $m Breastfeeding medicine $n Breastfeed Med $x MED00173017
- LZP __
- $a Pubmed-20220720